Enlivex Therapeutics
ENLV
ENLV
22 hedge funds and large institutions have $2.89M invested in Enlivex Therapeutics in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 6 closing their positions.
Holders
22
Holders Change
-3
Holders Change %
-12%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
6
Closed
6
Calls
$532K
Puts
$196K
Net Calls
+$336K
Net Calls Change
+$591K
Top Buyers
1 |
1
Morgan Stanley
New York
|
$148K |
2 |
![]()
2
Simplex Trading
Chicago,
Illinois
|
$19K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$83K |
4 |
4
Renaissance Technologies
New York
|
$290K |
5 |
5
State Street
Boston,
Massachusetts
|
$99K |